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ABSTRACT 
HYPOXIC STRESS IN ATHLETES WITH SICKLE CELL TRAIT 
By 
Samantha E. Reynolds 
Dr. John Young, Committee Chair 
Professor of Kinesiology 
University of Nevada, Las Vegas 
The purpose of this study was to examine various changes of blood measures in select 
athletes with sickle cell trait due (SCT) to exercise at different simulated altitudes (n=2). 
Previous studies have determined that athletes with sickle cell trait have complications in 
diminished oxygen environments, along with the potential for a lower oxygen carrying capacity 
with exertion. The study used a Hypoxico Altitude Training System in order to alter the 
oxygenated environment, and the subjects were evaluated at 2,470, 5,000 and 8,370 feet 
elevations. Arterial oxygen saturations were measured with pulse oximetry.  The study 
demonstrated that these athletes with sickle cell trait had arterial oxygen saturation percentages 
consistent with those of a hypoxic nature throughout an exercise bout.   
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CHAPTER 1 
INTRODUCTION 
Sickle cell trait (SCT) has received an overwhelming amount of attention in the last 10 
years, and it has become a factor to consider in conditioning practices for individuals that can 
possibly suffer from sickling crises. 1 Even though the muscles look and feel like normal, the 
adverse sensation of a sickling crisis will come in the form of a severe, ischemic type of muscle 
pain, stemming from the muscles lacking adequate blood supply.2 Athletes that deal with SCT, 
an abnormal hemoglobin gene, can experience adverse effects such as muscle cramping and 
inability to sustain endurance activities every time they are at a high level of exertion regardless 
of altitude, but the likelihood of presentation of symptoms become more severe with the addition 
of exertion at altitude.  
Since the first football death attributed to SCT in 1974, 1,3 this condition has been widely 
recognized as a serious risk for sickling crises precipitated by high intensity endurance activity. 
The rate of sickling varies, not only with the amount of abnormal sickled hemoglobin (HbS) in 
red blood cells, but also with sport participation, climate, and each individual’s fitness and 
conditioning level.4  Individuals with sickle cell trait are not excluded from sports participation, 
as this condition is separate from and cannot develop into the more severe sickle cell disease. 
However, the National Collegiate Athletic Association (NCAA) made it mandatory for all 
Division 1 athletes to be screened for this condition prior to participation.5 This mandate was 
made following a wrongful death suit filed by the parents of Dale Lloyd, a Rice University 
football player who collapsed and later died due to complications from an unknown sickle cell 
trait gene.5 
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 A sickling crisis can cause grave consequences for athletes suffering from them. These 
crises are characterized by an increased ratio of hemoglobin S, a specific type of hemoglobin that 
is more sensitive to the effects of unloading oxygen. When the oxygen is unloaded, hypoxia 
ensues to allow these cells to distort their shape, which causes them to abnormally clot the 
vessels, leading to vascular emergencies.6  In particular, competition at altitude presents a serious 
challenge to the athlete with SCT because of the added strain on the cardiovascular system from 
hypoxia.7 However, there is little evidence on the response of athletes with SCT in this 
environment. Therefore, the purpose of this study is to evaluate the sensitivity of athletes with a 
diagnosed SCT condition at various altitudes.  
Aim  
1. To examine various changes of blood measures in select athletes with sickle cell trait 
(SCT) due to exercise at simulated altitudes.  
 
Significance of Study 
 Physiologically, athletes competing at altitude struggle with the atmospheric changes, 
mainly due to their increased Hemoglobin S being more sensitive to the unloading of oxygen. 
This increased sensitivity paired with a lack of initial oxygen carrying capacity can precipitate a 
sickling crisis.3  There is currently a lack of knowledge concerning the interaction of different 
altitudes and exercise on athletes with sickle cell trait.  
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Limitations 
 A key limitation in this study was the limited sample size. Unfortunately, within the 
university population utilized, there are typically a limited number of athletes that are affected by 
this gene, so participants were scarce. Another limitation was that all participants were female 
limiting the results to only half of the affected population. Also, several uncontrollable factors 
also came into play, such as athlete’s hydration that affected the blood drawing process.  
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CHAPTER 2 
REVIEW OF RELATED LITERATURE 
 A normal red blood cell (RBC) is disc shaped, and has the oxygen carrying protein, 
hemoglobin (Hg).  RBCs lifespan is about 120 days in the blood stream. The spongy bone 
marrow’s function is to make new red blood cells to replace old and dysfunctional cells.8,9  
 Each hemoglobin molecule is made up of four sub-units that have a heme group and a 
globin molecule. Two alpha subunits are bound to two y-subunits in the fetus’ hemoglobin, and 
the y-subunits turn into beta subunits in an adult hemoglobin molecule. The alpha globin chain is 
found on Chromosome 16 and the beta globin is part of Chromosome 11. The sickled 
hemoglobin, HbS, is formed when there is a point mutation in the 6th position of the amino acid 
codon where valine is substituted for glutamic acid in the beta chain.10 Red blood cells that 
contain mostly HbS have a tendency to become stiff, distorted in shape, and as a result, can have 
great difficulty passing through small blood vessels.6 This abnormal chromosome causes a 40% 
presence of sickled hemoglobin in the blood of SCT individuals.4  SCT causes red blood cells to 
have a significantly shorter life span of 10-20 days, as opposed to the 120 days of normal red 
blood cells.8 SCT is characterized by anemia and recurrent episodes of painful small blood vessel 
obstruction by rigid, sickle-shaped red blood cells accompanied by inflammation and vascular 
adhesive processes.11 
 There is a SCT prevalence of about 8% among African Americans, and is much less 
common in Caucasian individuals, between 1 in 2,000 and 1 in 10,000 individuals.4 The 
populations aside from the African American population affected by SCT, accounting for only 
4% of carriers, will most likely be of Mediterranean, Middle Eastern, Indian, South American, or 
Central American descent.4 
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 In order to understand the pathophysiology of sickling, Eichner3 states that a “sickling 
foursome” has been used in an attempt to explain what is happening at the cellular level. The 
metabolic acidosis and hyperthermia in the cells cause a right shift of the oxygen dissociation 
curve. When the red blood cells become dehydrated, there is an increase in hemoglobin S, 
sickled hemoglobin. There is also an effect of severe hypoxemia because of the sudden maximal 
uptake of oxygen by the muscles. The presence of hypoxia and falling pH of the blood causes 
HbS to polymerize, which distorts the red blood cell shape.3 
 When a shift occurs in the oxygen dissociation curve, it is termed the Bohr effect, and it 
assists the unloading of oxygen from the hemoglobin in the blood molecules that are passing 
through active muscles.9 Red blood cells are composed of glycolytic enzymes, and also contain 
the enzyme diphosphoglycerate mutase (2,3-DPG). During exercise, these specific enzymes are 
inflated, particularly during exertion at high altitude. When 2,3-DPG binds to hemoglobin, it 
causes a rightward shift of the oxygen dissociation curve, decreasing hemoglobin affinity for 
oxygen.9 
 According to Katch, McArdle and Katch,12 hemoglobin is very sensitive to temperature 
and acidity, which are two of the factors of the sickling foursome. The binding of oxygen to 
hemoglobin is affected when either of these two conditions is modified. Both oxygen and carbon 
dioxide are able to bind to hemoglobin, and these molecules compete for the heme binding sites, 
with the one of highest concentration usually winning out. In situations where there is an 
increase of carbon dioxide, the blood becomes more acidic. When arterial blood is delivered to 
working muscle, carbon dioxide produced by muscle alters the affinity of hemoglobin for oxygen 
and oxygen is released to the muscle. Changes in temperature in muscle produce a similar result. 
The working muscles will produce heat when producing ATP. This increase in temperature 
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causes a right shift in the hemoglobin-oxygen dissociation curve, causing the binding of oxygen 
to decrease. This increase in temperature and decrease in pH is known as the Bohr effect, which 
states that as temperature and acidity increase, hemoglobin’s ability to bind decreases.12 
 Sickled red blood cells (RBCs) exhibit a potassium leak to shear stress, which is further 
increased at lower pH levels. Deformation of RBCs during the adhesion of sickled hemoglobin 
can induce this potassium leak, and make the polymerization of HbS worse. Hypoxia, decrease 
in pH and deformation of RBCs in muscles can increase this efflux of potassium. With the 
continuum of the sickling and efflux of potassium, severe hyperkalemia can ensue, putting the 
individual in grave danger of sudden death.6 
 Vascular function in SCT athletes is also impaired, although still raises some questions 
on its specific physiology. Nitric oxide (NO) is one of the most potent, naturally occurring 
vasodilators in the body, and a decrease in its availability causes endothelial dysfunction.13 
Minimal research has been conducted to examine plasma NO levels between SCT athletes and 
healthy individuals, and have found only small reductions in NO concentration in SCT 
individuals.13 The small amount of data available does not offer a clear answer of the vascular 
mechanisms, other than overall endothelial dysfunction due to distorted cells.13 
 Other occurrences for the vaso-occlusive crises are increased RBC aggregation, increased 
strength of RBC aggregates, increased blood viscosity and increased plasma level in vascular cell 
adhesion molecules (VCAM-1).13 When the muscles are being robbed of their needed oxygen, 
ischemia occurs. This ischemia typically appears as pain, and is most common in high vascular 
areas, such as long bones (due to bone marrow), spine, chest, and abdominal region.14 
 Cleary15 describes how sickle cell trait increases an affected athlete’s chance for sudden 
death during exertion. In terms of collapse for SCT athletes, there are several factors that are 
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common in many sickling episodes. Athletes will typically collapse while running, sometimes at 
altitude, sometimes for very short (300-800m) distances lasting less than three minutes, and 
almost always occurring at an athlete’s maximal intensity.15 Between 1977 and 1981, the rate of 
sudden unexplained death in black military recruits with SCT was 28 times higher than black 
recruits without SCT.15 
 A sickling crisis comes with some unique signs and symptoms, as compared to other 
conditions such as muscle cramping. Eichner3 describes several notable differences between 
these two conditions. First, with heat cramping, there are often preceding events leading up to an 
episode. Minutes to hours before a cramping episode, the athlete may see or feel their muscles 
start to twitch. With a sickling crisis, there are no preceding symptoms. The pain felt between a 
cramping athlete and sickling athlete will also be different. A cramping pain is normally an 
excruciating type of pain, as compared to a milder pain felt in a sickling athlete. The sickling 
athlete will complain of feeling weak, and no long be able to hold themselves up. The cramping 
athlete will no long be able to move due to full contraction of the muscles. On physical 
observation, sickling and cramping will also vary. In heat cramps, the muscles will be in full 
contraction, and cause extreme pain. A sickling athlete typically lays still and complains mostly 
of their legs both in pain and being weak, but their muscles will look and feel like normal. 
Finally, the response to treatment will be different. The athlete who is sickling will be able to 
return to a pre-crisis state after about 10-15 minutes in a cold tub, replacing fluids and receiving 
supplemental oxygen if necessary. It will only take this long for the sickling athlete due to the 
red blood cells returning to their previous oxygenated state. With a heat cramping athlete, this 
can last up to an hour, even with the athlete resting, replacing fluids, and stretching.3 
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 There are several complications associated with SCT. Connes et al16 reported impaired 
autonomic nervous system activity in carriers, implicating that carriers could be predisposed to 
cardiovascular problems. Exercise at high altitude can increase the athlete’s risk for a splenic 
infarction due to the large amounts of sickled cells into this organ.11 SCT may increase the risk 
for renal medullary carcinoma, hematuria, and exercise related sudden death. SCT is found 
predominantly in individuals with ancestry in sub-Saharan Africa where malaria is prevalent. 
The genetic adaptation for SCT provides protection against malaria.17 It has also been found that 
there is an increased risk for venous thromboembolism in females that use hormonal 
contraceptives and have SCT.17 Several sources state a trend of SCT and exertional 
rhabdomyolysis being linked.15,18 Rhabdomyolysis is defined as a muscle breakdown and 
consequential release of muscle toxins into the circulation.15 The aftermath of a sickling crisis 
can cause conditions such as metabolic acidosis, myoglobinuria, hyperkalemia, elevated plasma 
enzymes, renal failure, and “sudden death” within 48 hours.15 The possible sequelae of 
myglobinuria is a sign that rhabdomyolysis was very likely linked to the sickling crisis. There 
have been several studies on SCD patients, and the muscle biopsies done in order to determine 
the extent of damage at the cellular level. Several muscle biopsy results showed necrosis of 
myocytes and occlusion of blood vessels16  as well as several inflammatory cells present, which 
is very similar to autopsies done on SCT athletes that died following strenuous exercise. This 
also shows a connection between a sudden sickling death and the leakage of toxic myoglobin 
into the blood, in this case affecting the myocytes.  
In order for an athlete to become accustomed to the altitude, they must become 
acclimatized, which typically takes about 10-20 days. The proper production of erythropoietin 
can make this acclimatization time more beneficial. Erythropoeitin, or EPO, is a hormone that 
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acts on the bone marrow in order to produce new red blood cells. With the increased number of 
red blood cells comes an increase in oxygen carrying capacity in the blood. Athletes performing 
at altitudes of 12,000 feet or higher must be acclimatized. However, those participating in short 
duration, explosive activities have no immediate need for this acclimatization period.19 
 As an individual ascends to higher altitudes, the atmospheric (barometric) pressure starts 
to decrease which results in less oxygen per volume of air.9 According to the Institute for 
Altitude Medicine,19 high altitude starts at around 5,000 feet. At this altitude, the body starts to 
sense a climate and oxygen change and increases the individual’s breathing rate accordingly. As 
an individual begins to ascend, the atmospheric pressure starts to decrease. The percentage of 
oxygen in the air remains a consistent 21%, however, that 21% value is taken from a smaller 
value since there is less oxygen per volume.20 Due to this decrease in the partial pressure of 
oxygen, performance is decreased at higher altitudes.19 When athletes ascend to higher altitudes, 
the partial pressure ox oxygen decreases, which corresponds to a decrease in the arterial pressure 
of oxygen, leading to tissue hypoxia.21 As altitude increases, there is also a reduction in alveolar 
oxygen pressure and arterial oxygen saturation resulting in a decrease in availability of oxygen in 
muscle mitochondria.20 
 At altitude, aerobic exercise performance decreases whereas anaerobic performance 
potential remains stable.20 For activities lasting less than a minute of high intensity, the main 
energy source is phosphorylation and non-oxidative production of ATP. Since quick-agility type 
exercises are not oxygen dependent, explosive movements are not affected by altitude.21 
 Hypoxia at altitude also can cause grave danger for the heart and lungs of an athlete. In 
the general circulation, hypoxia affects the vascular tone of the pulmonary and systemic vessels.7 
There is an increase in heart rate that is related to the increase of sympathetic activity due to 
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resisted vessels.7 Bartsch7 states that for a given level of exercise, heart rate is greater at altitude 
and in order to maintain cardiac function, there is an increase in resting myocardial blood flow 
that is compensation for the lack of oxygen in the blood.7 
 Abnormal pulmonary function can contribute to the pathogenesis of systemic sickle cell 
formation.22 When lung function becomes abnormal, there is a disturbance of gas exchange that 
could worsen arterial hypoxemia and further promote formation of sickled cells throughout 
systemic circulation. It was also found that the rise in pulmonary vascular resistance was greatest 
at the highest altitude.23 Even though few studies have looked at the pulmonary function of those 
with SCT, there have been documentations made of reductions of forced vital capacity, and 
arterial oxyhemoglobin saturation.22 
Pulse oximetry is a monitoring technique in order to estimate the peripheral oxygen 
saturation (SpO2) of hemoglobin.24 This means of intervention is able to detect levels of 
hypoxemia, which is defined as insufficient oxygenation of arterial blood.25 A normal reading for 
arterial oxygen saturation is 95-100%. In a study performed by Tannheimer26, he examined a 
group of mountaineers’ oxygen saturations at altitude during maximal exertion, at rest, and 
during sleep. He found that their lowest oxygen saturation of 77.5% was during maximal 
exertion at an altitude of 4800m, suggesting a high level of oxygen depletion in a healthy 
individual.26 
 VO2 max is defined as the body’s maximal ability to extract oxygen from the air and 
deliver it to the tissues.19 The Fick Principle states that increases of hemoglobin and/or cardiac 
output could contribute to the maintenance of VO2 when saturated oxygen is reduced at 
altitude.20 An increase in hemoglobin paired with increases in cardiac output occur in hypoxia 
due to sympatho-andregenic activation.20 VO2 max is dependent on the amount of hemoglobin in 
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the cells under normal oxygenated situations. However, a change of 1g of hemoglobin 
corresponds to a VO2 change of about 3mL/min.27 Previous studies have shown that an 
individual’s VO2 max can decrease 1.5-3.5% for every 300m of additional altitude gained over 
1500m.20 
 Hypoxia will also trigger the increase of arterial ventilation through the carotid 
chemoreceptors, and can sometimes compensate for the lack of partial pressure of inspired 
oxygen (PiO2).28  When the muscles are forced to work anaerobically, this leads to the formation 
of lactic acid and hydrogen ions, and a build-up of these ions can then result in defective muscle 
contractile function which, consequently, can impair an individual’s ability to continue 
participating in exercise.28  Other adverse health effects also occur at altitude, such as increased 
blood pressure and heart rate, most likely because of the increased sympathetic nervous system 
activity.23 
 The sickled red blood cells will not be observable at rest in the peripheral blood flow, 
however, at high altitudes, sickling may be increased up to 9% of erythrocytes.4  As exercise 
stress and hypoxemia increase, SCT athletes can accumulate these abnormal cells in their arterial 
blood flow. If this happens, the cells cause an impedance of circulation and can rob vital organs 
of blood and nutrients.3 In one study, a military recruit with SCT cycled at high altitude, 
resulting in an eventual 28% of sickled cells in venous blood from the forearm.3 In situations 
with low oxygen levels, cells will become dehydrated and lose ions. Both of these losses can lead 
to an increase in intracellular hemoglobin concentration, which enhances polymerization of the 
red blood cells.29 
 Between 1970 and 2003, Eichner identified 30 cases of death that were associated with 
severe exercise.15 Military recruits, high school and college athletes, and even athletes as young 
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as 12 years old participating in youth football have been identified.30  It has been said that the 
higher intensity of the athlete, the earlier and greater the sickling.3 In order for medical 
professionals to be prepared for these sickling crises, we must first be able to identify at what 
specific climate changes are most detrimental to their health.  
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CHAPTER 3 
METHODOLOGY 
Study Design 
 This single blind quantitative study was designed to further understand the effects of 
sickle cell trait when these predisposed athletes are training at altitudes.  
 
Subjects 
 Two female collegiate athletes volunteered for this study. The two participants (average 
of 21r0 years, height: 184.15r5.38cm, 74.84r9.62 kg and BMI of 22r1.56) were on the 
volleyball and women’s basketball teams. Prior to medical clearance for sports participation, 
each athlete underwent a blood test to identify athletes with sickle cell trait. Each athlete who 
participated had a documented positive result on this test, and were medically cleared to play 
their respective sports by the head team physician. After approval by the IRB (Protocol Number: 
[862124-6]) and prior to participation, each subject signed an informed consent form for the 
protection of human subjects.  
Instrumentation 
 Subjects wore the Hypoxico altitude training mask, which altered the oxygenation state 
during the exertion test. The simulated altitudes used to test hemoglobin sensitivity were chosen 
in a random order, but incorporated heights of 2,470, 5,000 and 8,370 feet. 
Hypoxico Altitude Training System: Serial Number: CBB1014340118 
    New York, NY USA 
Pulse Oximetry Monitor: Oximeter Plus Oxi-Go, Serial Number: 113331501169 
    Roslyn Heights, NY USA 
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Treadmill: Landice, model L7, Serial Number: L7-101108 
    Randolph, NJ USA 
 
Procedures 
 Prior to each subject’s first trial day, they were evaluated to find their preferred running 
speed. The subjects were placed on a treadmill and blinded to the speed display while still 
allowing them to manipulate the speed controls. The subject was given the verbal command of 
choosing a pace that they could complete a 30-minute run. Once they found this speed, they 
returned the treadmill to the stop position. This was done three times, and an average of their 
three speeds was used for each subject’s individual trials at altitude.  
 Within the blood, hemoglobin, percent hemoglobin S, and hematocrit was evaluated at 
rest and after exertion. Normal hemoglobin levels for a non-pregnant female ranges between 
120-160 g/L.29 Hematocrit is a ratio measure of the blood which corresponds to the volume of 
red blood cells compared to the total blood volume, has a normal range between 36-48% in 
females.31 The hemoglobin electrophoresis evaluated the percentage of hemoglobin S in the 
subject’s blood. Normal values of oxygen saturation in the blood, evaluated by pulse oximetry, is 
between 95-100%.32  
 A venous blood draw was taken from each subject before and immediately following 
each trial. Proper phlebotomy procedures were followed.  
 
Protocol 
 During this case study, both subjects underwent three trials of the procedure, and each 
trial was separated with two days in between in order to replenish oxygen stores.8 Prior to each 
15 
 
trial, subjects’ blood was drawn by venous blood draw for a complete blood count in order to 
check hemoglobin levels at rest. Immediately following the blood draw, the subject performed a 
30-minute treadmill exertion test, running at their self-selected speed. Each subject wore the 
Hypoxico altitude simulating mask in order to change the oxygenated environments found at 
higher altitudes. A pulse oximetry monitor was used in order to monitor oxygen saturation. The 
probe was placed on the subject’s finger and is able to detect the amount to oxygen traveling to 
the most distal extremities.30 The three altitudes used to test the hemoglobin sensitivity were 
2,470, 5,000 and 8,370 feet, in order to assess the individual’s hemoglobin sensitivity at various 
oxygenation levels.  Immediately following each trial, another venous blood draw took place in 
order to monitor the changes in the hemoglobin, as well as hematocrit, plasma enzymes, and 
essential clotting factors. After the second blood test was collected, subjects were monitored by a 
supervising physician to ensure proper replenishment of oxygen and overall health and 
wellbeing.  
 
Safety 
 For each trial, essential safety measures for a sickling crisis were taken. There was a 
physician present for all trials in order to properly recognize and treat a sickling crisis if needed. 
In the event of a full body cramping episode, there was an ice immersion tank and an oxygen 
tank on site. If a cardiac emergency arose, there was an automated external defibrillator (AED) 
present. The pulse oximetry probe was also used for safety purposes, to track their need for extra 
oxygen. If the oxygen saturation value fell below 95%, it was deemed hypoxemia, and extra 
caution was taken for the remainder of the trial. Excessive caution and action is taken when the 
percentage falls below 90, which becomes a medical emergency for the subject. The signs and 
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symptoms of a sickling crisis were posted around the testing facility in order for the research 
team to recognize a possible emergency. The most common symptom of a sickling crisis is 
increasing pain and weakness in the working muscles, most commonly the legs, buttocks and/or 
low back. Rapid/difficulty breathing, confusion, and restlessness are signs of poor oxygenation.31  
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Chapter 4 
Results 
Two subjects who were identified with sickle cell trait during mandatory NCAA screening 
completed all three trials in this study. One subject was only able to complete one trial because 
of failures in blood draws. Data for the two subjects for all three trials, as well as the partial 
completion of trials for the third subject, are presented.  
Subjects self-selected running speeds for moderate intensity exercise trials at simulated altitudes 
are shown in Table 1.  
Table 1:  
Subject 753 meters 
(2,470 feet) 
1524 meters 
(5,000 feet) 
2551 meters 
(8,370 feet) 
Average Speed 
1 1.79 m/s 1.74 m/s 1.79 m/s 1.74 m/s 
2 2.01 m/s 1.88 m/s 2.06 m/s 1.97 m/s 
3 1.97 m/s 2.37 m/s 2.59 m/s 2.32 m/s 
Hematocrit, total hemoglobin and percent hemoglobin S did not change as a result of 30 minutes 
of exercise at any of the simulated altitudes for either of the subjects (Table 2).  
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Table 2: Hematocrit, Total Hemoglobin and Hemoglobin S 
  Subject 1   Subject 2   
Alt 
(m) 
 Hct 
% 
Total Hb 
g/dl 
Hb S 
% 
Hct 
% 
Total Hb 
g/dl 
Hb S 
% 
753  Pre 43.2 14.1 38.5 34.4 11.6 38.4 
 Post 44.7 14.6 38.4 34.8 11.7 38.7 
1524 Pre * * 38.6 34.6 11.2 38.3 
 Post 45.9 15.1 38.3 37.3 12.2 38.3 
2551 Pre 43.6 14.8 38.8 34.4 11.6 38.6 
 Post 45.1 15.3 38.8 36.3 12.2 38.4 
* Sample clotting prevented measurement of these values.  
 
 
 
 
 
19 
 
Alt (m) Subject 3 
 Hct % Total Hb g/dl Hb S % 
753 Pre * * * 
Post * * * 
1524 Pre 40.4 14.0 40.3 
Post 42.3 14.3 40.1 
2551 Pre * * * 
Post * * * 
*: trials not performed due to inability to draw blood 
 
Hemoglobin O2 saturation was determined by pulse oximetry before and at 10, 20, and 30 
minutes of exercise at each altitude (Table 3). O2 saturation did not change at the lowest altitude 
in either subject (Figure 1).  At 5,000 feet, there was a slight decrease in saturation which 
persisted throughout in subject 2 and recovered to baseline in subject 1. In neither case was 
desaturation problematic. At the highest altitude (8,370 feet), substantial hemoglobin 
desaturation occurred with no indication of a return to baseline as exercise continued. Despite a 
severe decrease in O2 saturation during exercise at the highest altitude, hemoglobin saturation 
returned to baseline levels after 3-5 minutes of recovery with rehydration.  
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Table 3: Oxygen saturation percent as determined by pulse oximetry 
 
 Subject 1    Subject 2   
Time 753 m 1524 m 2551m Time 753 m 1524 m 2551m 
Pre 97% 98% 99% Pre 98% 96% 99% 
10 min 96% 87% 82% 10 min 95% 90% 84% 
20 min 96% 85% 78% 20 min 97% 87% 83% 
30 min 95% 98% 76% 30 min 96% 88% 82% 
 
 
Subject 3 
Time 753m 1524m  2551m 
Pre - 98% - 
10 - 92% - 
20 - 92% - 
30 - 89% - 
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Figure 1: Hemoglobin O2 saturation during 30-minute exercise bout at simulated altitudes 
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CHAPTER 5 
DISCUSSION 
 Sickle cell trait (SCT) is a genetic condition caused by the heterozygous inheritance of a 
single defective globin gene.33  A point mutation in the 6th position of the beta chain, substituting 
valine for glutamic acid, leads to an increase in hemoglobin S (HbS), sickled hemoglobin.33 Red 
blood cells that contain mostly HbS have a tendency to become stiff, crescent moon shaped when 
stressed, and, as a result, can have difficulty passing through blood vessels.6 As these cells 
become more rigid and misshapen, a blockage occurs in the vessels, preventing nutrients in the 
circulation from continuing to areas in need. There are four main characteristics that stimulate 
the sickling of these cells.3 Metabolic acidosis and hyperthermia cause a rightward shift in the 
oxygen dissociation curve, the Bohr Effect, which facilitates a decreased hemoglobin’s affinity 
for oxygen. Hypoxia occurs as a result of a rapid increase in oxygen uptake by skeletal muscles, 
or a decrease in systemic oxygen content. Finally, dehydration of red blood cells causes a 
relative increase in the percentage of HbS, cells which are sickled.3,10 
 The Bohr Effect facilitates the unloading of oxygen from the hemoglobin in the blood 
molecules that is passing through active muscles.9 Red blood cells are made up of glycolytic 
enzymes, as well as the enzyme diphosphoglycerate (2,3-DPG). During a bout of exercise, the 
activity of these enzymes is increased, specifically during exertion at higher altitudes. When 2,3-
DPG binds to hemoglobin, the affinity of hemoglobin for oxygen is deceased.9 As oxygen is 
released, the concentration of deoxy hemoglobin S is increased, causing the cells to become stiff 
and sickled. 2,3-DPG is higher in SCT cells, increasing the potential for sickling.9 
 Barometric pressure decreases as altitude increases. At higher altitudes, the partial 
pressure of alveolar oxygen decreases, which corresponds to a decrease in arterial partial 
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pressure of oxygen, leading to tissue hypoxia.9,21 Red blood cells of SCT athletes may have 
irreversible qualities at an arterial partial pressure of about 25 mmHg, which is further elevated 
by a decreased pH of the blood.10 
 Pulmonary function is altered in athletes with sickle cell trait, and can contribute to 
systemic sickle cell formation.22 As lung function deteriorates, pulmonary-capillary gas 
exchange is affected. Arterial hypoxemia promotes sickled cells, starting on the venous side of 
the circulation when oxygen is unloaded from hemoglobin S. As exercise and stress increase, the 
sickled cells spread throughout the circulation, impeding blood flow to the heart, brain and 
muscles, robbing them of vital nutrients.3 Hypoxia affects the vascular tone of pulmonary and 
systemic vessels which causes an increase in sympathetic activity due to blocked vessels.7 With a 
lack of oxygen comes a lack of energy, forcing the muscles to work anaerobically. This process 
leads to the formation of lactic acid and hydrogen ions, which can cause defective muscle 
contractions, and inhibit the performance of prolonged exercise bouts.28 
 Vaso-occlusive crises are recurrent with sickle cell trait during high levels of exertion.13 
This occurs due to the obstruction of small blood vessels by the abnormally shaped sickled cells. 
When muscle ischemia occurs, pain occurs most commonly in highly vascularized areas such as 
the spine, chest and abdominal region.14 Short bursts of intense exercise can cause multiple 
physiological processes that could trigger the sickling of red blood cells. Decreases in both pH 
and plasma volume are paired with an increase in sympathetic blood flow, oxidative stress, heat 
production, tissue hypoxia, and the release of inflammatory mediators.32 Other conditions that 
may foster sickling include an increased core body temperature, increased blood viscosity, 
ambient heat index, and dehydration, but the role of these factors is unclear.10 
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 In the current study, the lowest hemoglobin oxygen saturation recorded was 76% at the 
highest altitude of 8,370 feet, or 2,551m. In an attempt to compare this value to an individual 
without SCT, we must look at other studies performed due the inability to use a control subject. 
Referring back to a study performed on mountaineers that recorded their oxygen saturations at 
maximal exertional, at rest and during sleep,26 their lowest value was 76.5% during maximal 
exertion at an altitude of 4,880m. Thus, the hemoglobin saturation of the SCT athletes in the 
current study was the same as the mountaineers at half the altitude, suggesting that the SCT 
athlete is more sensitive to losing their oxygen molecules than those individuals without the SCT 
condition.  
 In a similar study by A.S. Bowers et al,34 optimal hematocrit levels for females and males 
with both sickle cell trait and sickle cell disease were determined. Depending on the severity of 
the anemia of the individual, a normal hematocrit value for a woman with SCT ranges between 
35-40%. The authors concluded that females with SCT need an additional 4% increase in 
hematocrit to match non SCT women. In the current study, hematocrit in all but one trial of one 
of the subjects was below the optimal hematocrit level for females with SCT. Bowers also 
suggested that if the hematocrit level is too high, there are increased viscous properties due to 
increased cell volume.34 In contrast, if the hematocrit level falls too low, the oxygen carrying 
capacity of the blood is impaired (anemia). A lower than optimal hematocrit level over a long 
period of time, could indicate an increase in aerobic capacity due to heat acclimation, or an 
increase of plasma volume.34 Hematocrit changes with systemic dehydration, which occurs with 
hyperventilation at altitude. These changes could explain the altered hematocrit observed at the 
higher altitudes in the current study.  
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 The normal level of Hemoglobin S in the SCT athlete ranges from 35 to 45% of total 
hemoglobin.17 The risk of a sickling crisis within the low to high range of hemoglobin S is 
unknown. However, one can assume that the individual with a higher percentage of hemoglobin 
S, even within the normal range, may be predisposed to greater risk of sickling, especially during 
times of dehydration or hypoxemia. Conversely, athletes with percent hemoglobin S at the lower 
end of the normal range may be at relatively low risk and thus able to exercise somewhat more 
vigorously than those at the higher end.  
The aim of this study was to determine changes in blood in athletes with (SCT due to 
exercise at simulated altitudes. Contrary to our hypothesis, there were no unusual changes in the 
amount of hemoglobin, hematocrit, or percentage of hemoglobin S at different altitudes 
compared with rest, and no sickling crises occurred as a result of the exercise. In fact, the amount 
of hemoglobin in the blood seemed to be the least varying factor for the majority of the trials. 
Perhaps, the longer these athletes are running at a mild to moderate pace, their cells adapt to the 
change in the oxygen environment in order to keep them not only moving, but moving safely. 
The percent hemoglobin oxygen saturation returned to within 1% of the pre-test level, suggesting 
the possibility of adjustment to steady state exercise. Although the speed for each subject may  
not have been sufficient enough to cause oxidative stress, this may have clinical significance. In 
order to obtain the same conditioning effects as non-SCT athletes, other methods may need to be 
employed. Rather than implementing harder and faster sprints and shuttle runs, exercises that 
may exacerbate the SCT condition, perhaps the optimal way to achieve ideal aerobic capacity is 
mild intensity exercise over both an extended period of time in a single bout of exercise, as well 
as over an extended period of time to build up effects of cardiovascular benefits. In this study, 
trials performed at 2,470 and 5,000 feet indicated that, percent hemoglobin oxygen saturation 
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returned to normal at the 30-minute mark, suggesting that these athletes may need about 30 
minutes to acclimate themselves and their bodies to the changed environment.  
 Measurement of hemoglobin oxygen saturation, as measured via pulse oximetry, 
indicated how long it took the athletes with SCT to acclimatize to their changed environment. In 
the majority of the trials, the percent hemoglobin saturation was back to within 1% of the pre-test 
oxygen saturation. In the few trials that had not returned to within 1% of their pre-test values, 
specifically those at the highest altitude, oxygen saturation was back to pre-exercise levels after 
about five minutes of rest and rehydration.  
 Although our results did not show any abnormal changes in the blood parameters 
measured, the results may have clinical significance. A SCT athlete at rest has a normal level of 
hemoglobin S that ranges from 35-45% of the total hemoglobin content.17  Instead of simply 
obtaining a positive or negative result for these at risk athletes, an additional direction for these 
tests could be to obtain the specific percentage of hemoglobin S in their blood at rest. Knowing 
at which end of the 35-45% of the normal spectrum the athlete falls could indicate dangerous 
exertion levels. Greater precautions may be necessary for an athlete on the higher end of the 
range, as well as allowing for a longer time for acclimation to altitude. Starting levels of 
hemoglobin S in all trials for all subjects were 38%, which is in the middle of the normal range 
for SCT, which may account for the lack of any issues during the trials.  
 The National Athletic Trainers’ Association (NATA) has set forth guidelines for SCT 
athletes in order to protect them from overexertion.3 Slower increments in training intensity and 
longer recovery times in between bouts are recommended, as are restrictions on timed runs or 
any kind of all out exertion for 2-3 minutes with no recovery time. Other recommendations 
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include unrestricted hydration and adjusted work cycles based on heat and any other medical 
conditions, such as asthma.3 These guidelines are intended to set safe exercise limits for the SCT 
athlete. Since ischemia occurs most commonly in highly vascularized areas, cramping in the 
spine, chest, and abdominal region should be taken very seriously and treated like a medical 
emergency.14 Symptoms of these crises typically occur with no preceding symptoms and the 
muscles looking and feeling like normal. Athletes experiencing a crisis will typically be unable 
to hold themselves up, and complain of pain in their legs and buttocks, another common area due 
to the bone marrow within long bones.3 
Conclusions 
 It is important for the sports medicine team to work together in keeping the health and 
wellbeing of the athletes the utmost priority. In doing so, the team must educate themselves 
about specific conditions that may cause grave consequences to those under their care. Although 
there were no major variabilities in the blood measures tested in the current study, there are some 
relevant clinical indications. The current study concluded that the SCT athletes tested has a 
noticably increased sensitivity to altered oxygenation environments, but have a tendency to 
adjust to the change during steady state exercise. Adequate testing before certifying eligibility to 
participate may provide insight into potential cellular shortcomings these individuals may 
experience and suggest limits on their exertion level to reduce the risks of sickling crises. Further 
research is necessary on SCT athletes at altitudes and various environmental conditions in order 
to properly care for them.  
 
 
28 
 
 
 
 
 
 
 
 
APPENDIX A: IRB MATERIALS
28 
 
 
 
29 
 
 
 
 
30 
 
 
31 
 
 
 
 
 
 
 
 
APPENDIX B: MISCELLANEOUS APPROVALS 
32 
  
 862124-6, Expiration Date: 04/17/2017  Page 1 of 2 
 
 
 
INFORMED CONSENT  
Department of Kinesiology and Nutrition Sciences 
    
TITLE OF STUDY: The Effects of Altitude in Athletes with Sickle Cell Trait 
INVESTIGATOR(S): Samantha Reynolds, Dr. John Young, Dr. James Navalta, Dr. Kara 
(Miller) Radzak 
For questions or concerns about the study, you may contact Samantha Reynolds at (609) 682-0284, Dr. 
John Young at (702) 895-4626, Dr. James Navalta at (702) 895-2344.   
 
For questions regarding the rights of research subjects, any complaints or comments regarding the 
manner in which the study is being conducted, contact the UNLV Office of Research Integrity – 
Human Subjects at 702-895-2794, toll free at 877-895-2794 or via email at IRB@unlv.edu. 
    
 
Purpose of the Study 
Individuals who have inherited the sickle cell trait gene may experience some symptoms as they exert 
themselves during exercise, especially at higher altitudes. The purpose of this study is to evaluate the 
sensitivity of athletes with a diagnosed sickle cell trait to moderate intensity exercise at various 
altitudes by examining differences in your blood profile. 
 
Participants 
Participants in this study must be healthy collegiate athletes who have been diagnosed as having the 
sickle cell trait as a result of NCAA mandated screening.  
Dr. Rosenberg, Director, UNLV Sports Medicine Department, has given his approval for your 
participation in this study, should you choose to participate.  
 
Procedures  
If you volunteer to participate in this study, after giving informed consent, you will be asked to do the 
following: You will be asked to come to the Exercise Physiology laboratory (MPE 326) where you will 
complete a total of 3 trials. Each trial will consist of a 30 minute moderate intensity treadmill run at 
your self-selected preferred speed.  There will be a minimum of 2 days between each trial. While 
performing these trials, you will be wearing an altitude simulating face mask which will change the 
atmosphere to lower oxygen levels representing 3 different altitudes, in a randomized order.  A pulse 
oximeter will be worn on your finger to monitor the levels of oxygen saturation.  Before and after each 
trial a blood sample (about a tablespoon) will be taken from a vein in your arm by venipuncture by a 
qualified member of the research team for the determination of total blood count, hemoglobin, 
hematocrit, and the percentage of sickled cells.  These measurements will be done by a commercial 
laboratory and will be the only things measured in your blood.  After the second blood draw, you will 
be monitored by a supervising physician to ensure proper oxygen replenishment and overall well-being 
before being released from the laboratory.  
 
Benefits of Participation  
The direct benefit to you for participating is to gain a better understanding of how you respond to 
exercise at different altitudes and how your sickle cell trait gene may affect your athletic performance. 
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